Walmart launches private brand insulin to lower costs for diabetes patients

·1 min read

Walmart launched a private brand of insulin this week aimed at reducing costs for people with diabetes.

  • Walmart's ReliOn brand will offer analog insulin vials for $72.88 and FlexPens for $85.88, according to a company news release.

Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for free

Why it matters: Diabetes is an expensive and prevalent disease.

What they're saying: The new products will save customers 58-75%, according to Walmart. These numbers are based on costs before insurance.

Details: A prescription is required. The products will be available at Walmart pharmacies this week and at Sam's Club in mid-July.

More from Axios: Sign up to get the latest market trends with Axios Markets. Subscribe for free

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting